目的 分析2007—2022年安徽省淮河流域癌症早诊早治项目筛查结果,为优化癌症防治工作提供科学依据。方法 整理2007—2022年安徽省淮河流域癌症早诊早治项目筛查数据,按年份及项目地区分别计算不同癌种的检出率、早诊率、治疗率等。结果 2007—2022年安徽省共完成临床筛查174 611人次,平均检出率、早诊率、治疗率分别为0.64%、66.22%、93.53%。上消化道癌临床筛查50 970人次,检出率、早诊率、治疗率分别为0.69%、67.71%、96.86%;肝癌临床筛查123 641人次,检出率、早诊率、治疗率分别为0.62%、65.53%、92.01%。结论 安徽省淮河流域癌症早诊早治项目筛查工作初见成效,但仍需加强科普宣传和技术培训,助力项目高质量发展。
Abstract
Objective To analyze the results of cancer screening program in Huaihe River Basin of Anhui Province from 2007 to 2022,so as to provide scientific basis for optimizing cancer prevention and treatment. Methods The data of cancer screening program in Huaihe River Basin of Anhui Province from 2007 to 2022 were collected.The detection rates,early stage diagnosis rates and treatment rates of different cancer types were calculated by year and program area. Results From 2007 to 2022,a total of 174 611 residents were screened in the program,with average detection rate,early stage diagnosis rate and treatment rate of 0.64%,66.22% and 93.53%,respectively.50 970 residents received screening for upper gastrointestinal cancer,and the detection rate,early stage diagnosis rate and treatment rate were 0.69%,67.71% and 96.86%,respectively.123 641 residents received screening for liver cancer,and the detection rate,early stage diagnosis rate and treatment rate were 0.62%,65.53% and 92.01%,respectively. Conclusion The cancer screening program in Huaihe River Basin of Anhui Province has achieved initial results.However,it is necessary to strengthen publicity and technical training to promote the high-quality development of the program.
关键词
上消化道癌 /
肝癌 /
早诊早治 /
淮河流域 /
安徽
Key words
Upper gastrointestinal cancer /
Liver cancer /
Early diagnosis and treatment /
Huaihe River basin /
Anhui
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] 郑荣寿,张思维,孙可欣,等.2016年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2023,45(3):212-220.
[3] 刘志荣,陈叶纪.2016安徽省肿瘤登记年报[M].合肥:合肥工业大学出版社,2017.
[4] Zheng RS,Zhang SW,Zeng HM,et al.Cancer incidence and mortality in China,2016[J].J Natl Cancer Cent,2022,2(1):1-9.
[5] Chen R,Liu Y,Song G,et al.Effectiveness of one-time endoscopic screening programme in prevention of upper gastrointestinal cancer in China:a multicentre population-based cohort study[J].Gut,2021,70(2):251-260.
[6] Cao M,Li H,Sun D,et al.Cancer screening in China:the Current status,challenges,and suggestions[J].Cancer Lett,2021,506:120-127.
[7] 刘志荣,王华东.安徽省肿瘤登记地区癌症发病与死亡报告(2011—2015年)[M].合肥:安徽科学技术出版社,2023.
[8] 马恒敏,李晓,韩洪冰,等.2007—2021年山东省淮河流域癌症早诊早治项目筛查结果初步分析[J].中国肿瘤,2022,31(10):759-765.
[9] 罗鹏飞,孟娜,陆赛博,等.2007—2021年江苏省淮河流域癌症早诊早治项目主要结果及展望[J].中国肿瘤,2022,31(8):579-586.
[10] 康瑞华,刘曙正,陈琼,等.河南省淮河流域癌症筛查与早诊早治工作进展与展望[J].中国肿瘤,2022,31(11):847-852.
[11] 张澄,徐辉,吴珊,等.合肥市两所高校大学生癌症防治知识知晓率研究[J].安徽预防医学杂志,2020,26(3):184-187+203.
[12] 徐辉,张家祥,张澄,等.我国癌症健康教育现状与思考[J].安徽预防医学杂志,2022,28(2):127-130.
[13] 中华人民共和国中央人民政府.关于印发健康中国行动——癌症防治实施方案(2019—2022年)的通知[EB/OL].(2019-09-20)[2021-09-25].http://www.gov.cn/zhengce/zhengceku/2019-11/13/content_5451694.htm.
[14] 张澄,徐辉,吴珊,等.安徽省城乡居民癌症防治核心知识知晓情况分析[J].安徽医药,2022,26(5):921-924.
[15] 李德喜,梁岭,王华东,等.安徽省淮河流域食管癌高危人群内镜筛查参与率、病变检出率及相关影响因素分析[J].中国肿瘤,2023,32(5):378-386.
[16] 董腾飞,吕逸丽,刘玲丽,等.2013—2018年安徽省淮河流域胃癌高危人群内镜筛查参与率及其影响因素分析[J].现代预防医学,2022,49(10):1729-1734+1746.
基金
中国消化道早癌医师共同成长计划科研项目(GTCZ-2021-AH-34-0010)
PDF(757 KB)
